Xiaojun Yi
Papers
1
Total Citations
3
H-Index
1
About
Xiaojun Yi is a leading urologic oncologist whose research focuses on optimizing surgical outcomes for upper tract urothelial carcinoma (UTUC). His major contributions center on comparative effectiveness research, systematically evaluating open, laparoscopic, and robotic radical nephroureterectomy techniques. Yi’s landmark work, published in 2025, directly compares these three surgical approaches, analyzing not only perioperative outcomes and costs but also introducing the innovative "tetrafecta" composite outcome—a novel metric that captures multiple dimensions of surgical success. This study, already garnering 3 citations shortly after publication, provides crucial evidence for surgeons selecting the optimal approach for UTUC patients. By rigorously assessing how surgical modality impacts both immediate recovery and long-term survival, Yi bridges the gap between technical innovation and meaningful patient outcomes. His work is particularly notable for its practical implications, helping urologists weigh the benefits of robotic surgery against its higher costs. For researchers and clinicians alike, Yi’s scholarship represents a vital step toward evidence-based, patient-centered decision-making in the surgical management of upper tract malignancies.
Research Focus
Key Achievements
Top Papers
- 1